TROENDELAG SPA (TRSB.OL) Fundamental Analysis & Valuation

OSL:TRSB • NO0010788268

Current stock price

113.12 NOK
-0.88 (-0.77%)
Last:

This TRSB.OL fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. TRSB.OL Profitability Analysis

1.1 Basic Checks

  • In the past year TRSB was profitable.
  • TRSB had a negative operating cash flow in the past year.
TRSB.OL Yearly Net Income VS EBIT VS OCF VS FCFTRSB.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 2025 0 -200M -400M -600M -800M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 0.36%, TRSB is doing worse than 85.45% of the companies in the same industry.
  • TRSB has a worse Return On Equity (3.11%) than 80.00% of its industry peers.
Industry RankSector Rank
ROA 0.36%
ROE 3.11%
ROIC N/A
ROA(3y)0.38%
ROA(5y)N/A
ROE(3y)3.34%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
TRSB.OL Yearly ROA, ROE, ROICTRSB.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 2025 1 2 3

1.3 Margins

  • TRSB's Profit Margin of 10.55% is on the low side compared to the rest of the industry. TRSB is outperformed by 88.18% of its industry peers.
  • In the last couple of years the Profit Margin of TRSB has grown nicely.
  • TRSB does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) 10.55%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y25.39%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
TRSB.OL Yearly Profit, Operating, Gross MarginsTRSB.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 2025 2 4 6 8 10

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. TRSB.OL Health Analysis

2.1 Basic Checks

  • TRSB does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for TRSB remains at a similar level compared to 1 year ago.
  • Compared to 1 year ago, TRSB has a worse debt to assets ratio.
TRSB.OL Yearly Shares OutstandingTRSB.OL Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 2025 1M 2M 3M 4M
TRSB.OL Yearly Total Debt VS Total AssetsTRSB.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 2025 2B 4B 6B 8B 10B

2.2 Solvency

  • TRSB has a Debt/Equity ratio of 2.10. This is a high value indicating a heavy dependency on external financing.
  • The Debt to Equity ratio of TRSB (2.10) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 2.1
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC6.01%
TRSB.OL Yearly LT Debt VS Equity VS FCFTRSB.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 2025 0 1B 2B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
TRSB.OL Yearly Current Assets VS Current LiabilitesTRSB.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 2025 5M 10M 15M 20M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. TRSB.OL Growth Analysis

3.1 Past

  • TRSB shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -18.27%.
  • TRSB shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 70.36% yearly.
  • TRSB shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 8.05%.
  • TRSB shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 35.87% yearly.
EPS 1Y (TTM)-18.27%
EPS 3Y70.36%
EPS 5YN/A
EPS Q2Q%-83.99%
Revenue 1Y (TTM)8.05%
Revenue growth 3Y35.87%
Revenue growth 5YN/A
Sales Q2Q%10.16%

3.2 Future

  • The Earnings Per Share is expected to grow by 8.43% on average over the next years. This is quite good.
  • TRSB is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.95% yearly.
EPS Next Y7.99%
EPS Next 2Y8.43%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year6.38%
Revenue Next 2Y5.95%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
TRSB.OL Yearly Revenue VS EstimatesTRSB.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 2027 100M 200M 300M
TRSB.OL Yearly EPS VS EstimatesTRSB.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 2 4 6 8

More info and screens

Find the best growth stocksShow best growing peers

2

4. TRSB.OL Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 14.79 indicates a correct valuation of TRSB.
  • Compared to the rest of the industry, the Price/Earnings ratio of TRSB indicates a rather expensive valuation: TRSB more expensive than 89.09% of the companies listed in the same industry.
  • The average S&P500 Price/Earnings ratio is at 25.50. TRSB is valued slightly cheaper when compared to this.
  • TRSB is valuated correctly with a Price/Forward Earnings ratio of 12.62.
  • Based on the Price/Forward Earnings ratio, TRSB is valued a bit more expensive than 71.82% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of TRSB to the average of the S&P500 Index (22.67), we can say TRSB is valued slightly cheaper.
Industry RankSector Rank
PE 14.79
Fwd PE 12.62
TRSB.OL Price Earnings VS Forward Price EarningsTRSB.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
TRSB.OL Per share dataTRSB.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100 150 200

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates TRSB does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)1.85
PEG (5Y)N/A
EPS Next 2Y8.43%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. TRSB.OL Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 4.42%, TRSB is a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 4.75, TRSB has a dividend in line with its industry peers.
  • Compared to an average S&P500 Dividend Yield of 1.89, TRSB pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.42%

5.2 History

Dividend Growth(5Y)N/A
Div Incr YearsN/A
Div Non Decr YearsN/A

5.3 Sustainability

DPN/A
EPS Next 2Y8.43%
EPS Next 3YN/A
TRSB.OL Yearly Income VS Free CF VS DividendTRSB.OL Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2022 2023 2024 2025 0 -200M -400M -600M -800M

More info and screens

Find the best dividend stocksShow peers with best dividend

TRSB.OL Fundamentals: All Metrics, Ratios and Statistics

TROENDELAG SPA

OSL:TRSB (3/19/2026, 7:00:00 PM)

113.12

-0.88 (-0.77%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)02-13
Earnings (Next)N/A
Inst Owners3.82%
Inst Owner ChangeN/A
Ins Owners3.23%
Ins Owner ChangeN/A
Market Cap540.71M
Revenue(TTM)346.57M
Net Income(TTM)36.58M
Analysts37.78
Price Target105.06 (-7.13%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.42%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)3.54%
Min Revenue beat(2)-0.53%
Max Revenue beat(2)7.61%
Revenue beat(4)2
Avg Revenue beat(4)3.63%
Min Revenue beat(4)-5.84%
Max Revenue beat(4)13.29%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-8.34%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)4.96%
Revenue NY rev (3m)4.96%
Valuation
Industry RankSector Rank
PE 14.79
Fwd PE 12.62
P/S 1.56
P/FCF N/A
P/OCF N/A
P/B 0.46
P/tB 0.48
EV/EBITDA N/A
EPS(TTM)7.65
EY6.76%
EPS(NY)8.97
Fwd EY7.93%
FCF(TTM)-44.75
FCFYN/A
OCF(TTM)-39.26
OCFYN/A
SpS72.5
BVpS245.9
TBVpS237.58
PEG (NY)1.85
PEG (5Y)N/A
Graham Number205.73
Profitability
Industry RankSector Rank
ROA 0.36%
ROE 3.11%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 10.55%
GM N/A
FCFM N/A
ROA(3y)0.38%
ROA(5y)N/A
ROE(3y)3.34%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y25.39%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 2.1
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 7.58%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score2
WACC6.01%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)11.38%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-18.27%
EPS 3Y70.36%
EPS 5YN/A
EPS Q2Q%-83.99%
EPS Next Y7.99%
EPS Next 2Y8.43%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)8.05%
Revenue growth 3Y35.87%
Revenue growth 5YN/A
Sales Q2Q%10.16%
Revenue Next Year6.38%
Revenue Next 2Y5.95%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y2.46%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-0.48%
OCF growth 3YN/A
OCF growth 5YN/A

TROENDELAG SPA / TRSB.OL Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for TROENDELAG SPA?

ChartMill assigns a fundamental rating of 2 / 10 to TRSB.OL.


Can you provide the valuation status for TROENDELAG SPA?

ChartMill assigns a valuation rating of 2 / 10 to TROENDELAG SPA (TRSB.OL). This can be considered as Overvalued.


Can you provide the profitability details for TROENDELAG SPA?

TROENDELAG SPA (TRSB.OL) has a profitability rating of 1 / 10.


Can you provide the financial health for TRSB stock?

The financial health rating of TROENDELAG SPA (TRSB.OL) is 0 / 10.